img

Global Pediatric Gastrointestinal Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pediatric Gastrointestinal Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Pediatric Gastrointestinal Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Gastrointestinal Drugs market research.
Key companies engaged in the Pediatric Gastrointestinal Drugs industry include AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals and Perrigo, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Pediatric Gastrointestinal Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Pediatric Gastrointestinal Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Gastrointestinal Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical
Segment by Type
Tablets
Pills
Oral Liquid

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pediatric Gastrointestinal Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Tablets
1.2.3 Pills
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Pediatric Gastrointestinal Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Gastrointestinal Drugs Market Perspective (2018-2034)
2.2 Pediatric Gastrointestinal Drugs Growth Trends by Region
2.2.1 Global Pediatric Gastrointestinal Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Pediatric Gastrointestinal Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2024-2034)
2.3 Pediatric Gastrointestinal Drugs Market Dynamics
2.3.1 Pediatric Gastrointestinal Drugs Industry Trends
2.3.2 Pediatric Gastrointestinal Drugs Market Drivers
2.3.3 Pediatric Gastrointestinal Drugs Market Challenges
2.3.4 Pediatric Gastrointestinal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue
3.1.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue (2018-2023)
3.1.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Gastrointestinal Drugs Revenue
3.4 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio
3.4.1 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Gastrointestinal Drugs Revenue in 2024
3.5 Pediatric Gastrointestinal Drugs Key Players Head office and Area Served
3.6 Key Players Pediatric Gastrointestinal Drugs Product Solution and Service
3.7 Date of Enter into Pediatric Gastrointestinal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Gastrointestinal Drugs Breakdown Data by Type
4.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2024-2034)
5 Pediatric Gastrointestinal Drugs Breakdown Data by Application
5.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pediatric Gastrointestinal Drugs Market Size (2018-2034)
6.2 North America Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023)
6.4 North America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Gastrointestinal Drugs Market Size (2018-2034)
7.2 Europe Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023)
7.4 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size (2018-2034)
8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Gastrointestinal Drugs Market Size (2018-2034)
9.2 Latin America Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023)
9.4 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size (2018-2034)
10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Introduction
11.1.4 AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pediatric Gastrointestinal Drugs Introduction
11.2.4 Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Aptalis
11.3.1 Aptalis Company Detail
11.3.2 Aptalis Business Overview
11.3.3 Aptalis Pediatric Gastrointestinal Drugs Introduction
11.3.4 Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.3.5 Aptalis Recent Development
11.4 Eisai
11.4.1 Eisai Company Detail
11.4.2 Eisai Business Overview
11.4.3 Eisai Pediatric Gastrointestinal Drugs Introduction
11.4.4 Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.4.5 Eisai Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pediatric Gastrointestinal Drugs Introduction
11.5.4 Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Zeria (Tillotts)
11.6.1 Zeria (Tillotts) Company Detail
11.6.2 Zeria (Tillotts) Business Overview
11.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Introduction
11.6.4 Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.6.5 Zeria (Tillotts) Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Introduction
11.7.4 GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Detail
11.8.2 Salix Pharmaceuticals Business Overview
11.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Introduction
11.8.4 Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.8.5 Salix Pharmaceuticals Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Detail
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Pediatric Gastrointestinal Drugs Introduction
11.9.4 Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.9.5 Perrigo Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Pediatric Gastrointestinal Drugs Introduction
11.10.4 Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.10.5 Abbott Recent Development
11.11 Honz Pharmaceutical
11.11.1 Honz Pharmaceutical Company Detail
11.11.2 Honz Pharmaceutical Business Overview
11.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.11.4 Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.11.5 Honz Pharmaceutical Recent Development
11.12 Shandong DYNE Marine Biopharmaceutical
11.12.1 Shandong DYNE Marine Biopharmaceutical Company Detail
11.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview
11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.12.4 Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.12.5 Shandong DYNE Marine Biopharmaceutical Recent Development
11.13 Sunflower Pharmaceutical
11.13.1 Sunflower Pharmaceutical Company Detail
11.13.2 Sunflower Pharmaceutical Business Overview
11.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.13.4 Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.13.5 Sunflower Pharmaceutical Recent Development
11.14 Jiangzhong Pharmaceutical
11.14.1 Jiangzhong Pharmaceutical Company Detail
11.14.2 Jiangzhong Pharmaceutical Business Overview
11.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.14.4 Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.14.5 Jiangzhong Pharmaceutical Recent Development
11.15 Yabao Pharmaceutical
11.15.1 Yabao Pharmaceutical Company Detail
11.15.2 Yabao Pharmaceutical Business Overview
11.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.15.4 Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.15.5 Yabao Pharmaceutical Recent Development
11.16 Jumpcan Pharmaceutical
11.16.1 Jumpcan Pharmaceutical Company Detail
11.16.2 Jumpcan Pharmaceutical Business Overview
11.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.16.4 Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.16.5 Jumpcan Pharmaceutical Recent Development
11.17 Hansen Pharmaceutical
11.17.1 Hansen Pharmaceutical Company Detail
11.17.2 Hansen Pharmaceutical Business Overview
11.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.17.4 Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023)
11.17.5 Hansen Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Tablets
Table 3. Key Players of Pills
Table 4. Key Players of Oral Liquid
Table 5. Global Pediatric Gastrointestinal Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Pediatric Gastrointestinal Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Pediatric Gastrointestinal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pediatric Gastrointestinal Drugs Market Share by Region (2018-2023)
Table 9. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Pediatric Gastrointestinal Drugs Market Share by Region (2024-2034)
Table 11. Pediatric Gastrointestinal Drugs Market Trends
Table 12. Pediatric Gastrointestinal Drugs Market Drivers
Table 13. Pediatric Gastrointestinal Drugs Market Challenges
Table 14. Pediatric Gastrointestinal Drugs Market Restraints
Table 15. Global Pediatric Gastrointestinal Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pediatric Gastrointestinal Drugs Market Share by Players (2018-2023)
Table 17. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2024)
Table 18. Ranking of Global Top Pediatric Gastrointestinal Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pediatric Gastrointestinal Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Gastrointestinal Drugs Product Solution and Service
Table 22. Date of Enter into Pediatric Gastrointestinal Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Gastrointestinal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Pediatric Gastrointestinal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Pediatric Gastrointestinal Drugs Product
Table 50. AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Pediatric Gastrointestinal Drugs Product
Table 55. Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Aptalis Company Detail
Table 58. Aptalis Business Overview
Table 59. Aptalis Pediatric Gastrointestinal Drugs Product
Table 60. Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 61. Aptalis Recent Development
Table 62. Eisai Company Detail
Table 63. Eisai Business Overview
Table 64. Eisai Pediatric Gastrointestinal Drugs Product
Table 65. Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 66. Eisai Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Pediatric Gastrointestinal Drugs Product
Table 70. Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Zeria (Tillotts) Company Detail
Table 73. Zeria (Tillotts) Business Overview
Table 74. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product
Table 75. Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 76. Zeria (Tillotts) Recent Development
Table 77. GlaxoSmithKline Company Detail
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product
Table 80. GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Salix Pharmaceuticals Company Detail
Table 83. Salix Pharmaceuticals Business Overview
Table 84. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product
Table 85. Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 86. Salix Pharmaceuticals Recent Development
Table 87. Perrigo Company Detail
Table 88. Perrigo Business Overview
Table 89. Perrigo Pediatric Gastrointestinal Drugs Product
Table 90. Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 91. Perrigo Recent Development
Table 92. Abbott Company Detail
Table 93. Abbott Business Overview
Table 94. Abbott Pediatric Gastrointestinal Drugs Product
Table 95. Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 96. Abbott Recent Development
Table 97. Honz Pharmaceutical Company Detail
Table 98. Honz Pharmaceutical Business Overview
Table 99. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 100. Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 101. Honz Pharmaceutical Recent Development
Table 102. Shandong DYNE Marine Biopharmaceutical Company Detail
Table 103. Shandong DYNE Marine Biopharmaceutical Business Overview
Table 104. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product
Table 105. Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 106. Shandong DYNE Marine Biopharmaceutical Recent Development
Table 107. Sunflower Pharmaceutical Company Detail
Table 108. Sunflower Pharmaceutical Business Overview
Table 109. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 110. Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 111. Sunflower Pharmaceutical Recent Development
Table 112. Jiangzhong Pharmaceutical Company Detail
Table 113. Jiangzhong Pharmaceutical Business Overview
Table 114. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 115. Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 116. Jiangzhong Pharmaceutical Recent Development
Table 117. Yabao Pharmaceutical Company Detail
Table 118. Yabao Pharmaceutical Business Overview
Table 119. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 120. Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 121. Yabao Pharmaceutical Recent Development
Table 122. Jumpcan Pharmaceutical Company Detail
Table 123. Jumpcan Pharmaceutical Business Overview
Table 124. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 125. Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 126. Jumpcan Pharmaceutical Recent Development
Table 127. Hansen Pharmaceutical Company Detail
Table 128. Hansen Pharmaceutical Business Overview
Table 129. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 130. Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2023) & (US$ Million)
Table 131. Hansen Pharmaceutical Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Gastrointestinal Drugs Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Pediatric Gastrointestinal Drugs Market Share by Type: 2024 VS 2034
Figure 3. Tablets Features
Figure 4. Pills Features
Figure 5. Oral Liquid Features
Figure 6. Global Pediatric Gastrointestinal Drugs Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Pediatric Gastrointestinal Drugs Market Share by Application: 2024 VS 2034
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Pediatric Gastrointestinal Drugs Report Years Considered
Figure 12. Global Pediatric Gastrointestinal Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Pediatric Gastrointestinal Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Pediatric Gastrointestinal Drugs Market Share by Region: 2024 VS 2034
Figure 15. Global Pediatric Gastrointestinal Drugs Market Share by Players in 2024
Figure 16. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Gastrointestinal Drugs Revenue in 2024
Figure 18. North America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 20. United States Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 24. Germany Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Gastrointestinal Drugs Market Share by Region (2018-2034)
Figure 32. China Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 40. Mexico Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 44. Turkey Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 48. Aptalis Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 49. Eisai Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 51. Zeria (Tillotts) Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 53. Salix Pharmaceuticals Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 54. Perrigo Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 56. Honz Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 57. Shandong DYNE Marine Biopharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 58. Sunflower Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 59. Jiangzhong Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 60. Yabao Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 61. Jumpcan Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 62. Hansen Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed